Alzheimer's Disease(AD)
8
4
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Community-based Screening for Alzheimer's Disease
InRAD Observational Study
A Graphene Far-infrared Intervention Study of Cognitive Status in Older Adults
A Study of QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease
UPenn Observational Research Repository on Neurodegenerative Disease
Ultrasound-Guided Stellate Ganglion Block for Alzheimer's Disease
Neuclare Device for Temporary Improvement of Executive Function in Patients With Mild Cognitive Impairment and Prodromal Alzheimer's Disease
12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease